CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 19, 2004--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
Company's chairman, president and chief executive officer, will be
speaking to investors at the 4th Annual Smith Barney Specialty
Pharmaceutical Conference on Tuesday, February 24, at 8:00 a.m.
Eastern Time in New York City.
Dr. Plachetka's presentation will be webcast live and archived on
POZEN's home page at www.pozen.com.
Dr. Plachetka will also be presenting to investors at the NCINVEST
2004 Conference on Thursday, February 26, 2004 in Chapel Hill, N.C.
The presentation will not be webcast.
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Product development efforts
are focused on diseases with unmet medical needs where POZEN can
improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed the largest and most advanced product
pipeline in the field of migraine. POZEN has development and
commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and
Nycomed. The company's common stock is traded on The Nasdaq Stock
Market under the symbol "POZN". For detailed company information,
including copies of this and other press releases, see POZEN's
Lisa Barthelemy, Director, Investor Relations
John Barnhardt, Vice President, Finance and